搜索临床试验以:Fruquintinib 和 Camrelizumab 的组合
总计148089个结果
-
Beijing Biostar Pharmaceuticals Co., Ltd.招聘中
-
Roswell Park Cancer InstituteNational Comprehensive Cancer Network招聘中去势抵抗性前列腺癌 | IV 期前列腺癌 AJCC v8 | IVA 期前列腺癌 AJCC v8 | IVB 期前列腺癌 AJCC v8美国
-
Rockefeller UniversityNational Institute on Drug Abuse (NIDA)完全的
-
Mansoura University Hospital完全的
-
Eunice Kennedy Shriver National Institute of Child...University of Pittsburgh; University of Washington; University of Texas; RTI International; Indiana...未知
-
University of OxfordUniversity of Turku; National Institute for Public Health and the Environment (RIVM)完全的
-
University of Giessen完全的
-
Jiangsu HengRui Medicine Co., Ltd.招聘中
-
1ST Biotherapeutics, Inc.Merck Sharp & Dohme LLC招聘中
-
Hutchmed完全的
-
Stuart FiskGilead Sciences; University of Pittsburgh; Allegheny Singer Research Institute (also known as... 和其他合作者终止
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb撤销
-
Tianjin Medical University Cancer Institute and...尚未招聘
-
Guangzhou Institute of Respiratory DiseaseJiangsu HengRui Medicine Co., Ltd.; BGI-Shenzhen完全的
-
Cancer Institute and Hospital, Chinese Academy...The First Affiliated Hospital with Nanjing Medical University; Fujian Cancer Hospital; Henan Cancer... 和其他合作者招聘中
-
West China Hospital招聘中BRAF V600E 突变 /MSS 转移性结直肠癌 | 维罗非尼(BRAFi)加西妥昔单抗(EGFRi)联合PD-1单克隆抗体中国
-
Astex Pharmaceuticals, Inc.完全的
-
Lei Li招聘中
-
Compugen Ltd招聘中多发性骨髓瘤 | 卵巢癌 | 肺癌 | 晚期癌症 | 结肠癌 | 浆细胞肿瘤 | HNSCC | 微卫星稳定性结直肠癌 | MSS-CRC校验码美国
-
Dow University of Health Sciences招聘中
-
Cyteir Therapeutics, Inc.主动,不招人软组织肉瘤 | 滤泡性淋巴瘤 | 乳腺癌 | 头颈癌 | 小细胞肺癌 | 多发性骨髓瘤 | 胰腺癌 | 卵巢癌 | 套细胞淋巴瘤 | 头颈部鳞状细胞癌 | 三阴性乳腺癌 | DLBCL | 非霍奇金淋巴瘤 | 恶性肿瘤 | 慢性淋巴细胞白血病美国
-
Cancer Institute and Hospital, Chinese Academy...Jiangsu HengRui Medicine Co., Ltd.招聘中
-
Centers for Disease Control and PreventionKamuzu University of Health Sciences完全的
-
Swansea UniversityOsteopathic Foundation; University College of Osteopathy完全的